TBPN cover image

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN

00:00

How Does the Veterinary FDA Path Differ from Human Drugs?

Celine outlines faster, cheaper canine trials, FDA incentives, exclusivity, and the importance of safety for preventative longevity medicines.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app